This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Myoclonus can be induced by many drugs, including antiparkinsonian drugs, such as levodopa and bromocriptine1; but although there has been one report of amantadine-induced “vocal” myoclonus,2 we have seen no reports of generalized myoclonus induced by amantadine. We describe three patients with amantadine-induced cortical myoclonus.
Patient 1.
A 87-year-old woman with chronic renal failure on hemodialysis developed generalized myoclonic jerking at the end of April 1999 and was admitted to our department on May 27. Amantadine hydrochloride (HCL), 100 mg/d, had been administered at another hospital since April 2 1999, along with prazosin HCL, atenolol, ticlopidine HCL and l-thyroxine. She was in a confused state. Severe, asymmetrical, and multifocal myoclonic jerking was seen in all extremities, and involved her neck, tongue, and face muscles. Her myoclonus and confusion disappeared about two weeks after the discontinuation of amantadine on June 1. The dosage of other drugs was not changed. The plasma level of amantadine was 3,198 ng/mL on admission, decreasing to 407 ng/mL on June 13 and 47 ng/mL by June 28.
Patient 2.
A 78-year-old woman with a 4-year history of PD (Hoehn and Yahr stage IV) developed mild, asymmetrical and multifocal myoclonic jerking of all extremities in November 1997. She had been taking 40 mg …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
